Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists

[Display omitted] An X-ray crystal structure of one of our previously discovered RORγt inverse agonists bound to the RORγt ligand binding domain revealed that the cyclohexane carboxylic acid group of compound 2 plays a significant role in RORγt binding, forming four hydrogen bonding and ionic intera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2019-08, Vol.29 (16), p.2265-2269
Hauptverfasser: Lu, Zhonghui, Duan, James J.-W., Xiao, Haiyun, Neels, James, Wu, Dauh-Rurng, Weigelt, Carolyn A., Sack, John S., Khan, Javed, Ruzanov, Max, An, Yongmi, Yarde, Melissa, Karmakar, Ananta, Vishwakrishnan, Sureshbabu, Baratam, Venkata, Shankarappa, Harisha, Vanteru, Sridhar, Babu, Venkatesh, Basha, Mushkin, Kumar Gupta, Arun, Kumaravel, Selvakumar, Mathur, Arvind, Zhao, Qihong, Salter-Cid, Luisa M., Carter, Percy H., Murali Dhar, T.G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2269
container_issue 16
container_start_page 2265
container_title Bioorganic & medicinal chemistry letters
container_volume 29
creator Lu, Zhonghui
Duan, James J.-W.
Xiao, Haiyun
Neels, James
Wu, Dauh-Rurng
Weigelt, Carolyn A.
Sack, John S.
Khan, Javed
Ruzanov, Max
An, Yongmi
Yarde, Melissa
Karmakar, Ananta
Vishwakrishnan, Sureshbabu
Baratam, Venkata
Shankarappa, Harisha
Vanteru, Sridhar
Babu, Venkatesh
Basha, Mushkin
Kumar Gupta, Arun
Kumaravel, Selvakumar
Mathur, Arvind
Zhao, Qihong
Salter-Cid, Luisa M.
Carter, Percy H.
Murali Dhar, T.G.
description [Display omitted] An X-ray crystal structure of one of our previously discovered RORγt inverse agonists bound to the RORγt ligand binding domain revealed that the cyclohexane carboxylic acid group of compound 2 plays a significant role in RORγt binding, forming four hydrogen bonding and ionic interactions with RORγt. SAR studies centered around the cyclohexane carboxylic acid group led to identification of several structurally diverse and more potent compounds, including new carboxylic acid analogues 7 and 20, and cyclic sulfone analogues 34 and 37. Notably, compounds 7 and 20 were found to maintain the desirable pharmacokinetic profile of 2.
doi_str_mv 10.1016/j.bmcl.2019.06.036
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2250632727</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X19304160</els_id><sourcerecordid>2250632727</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-7127363802f810f4637500bb2359372ef28d0d1f6ee4ce8490b62f584e9645da3</originalsourceid><addsrcrecordid>eNp9UUuK3DAQFSEh09PJBbIIWvbA2Cl9LNuQzTDkMzAw0CSQnZDt8kSNWnIkd4PvkNvkHjlT1PQky6yKqnr1quo9Qt4wKBkw9W5XdvvelRxYW4IqQahnZMWkkoWQUD0nK2gVFE0rv12Qy5R2AEyClC_JhWC8qqGpV-Tn3YB-tqPtzWyDp2GkU5hz6ZomdNjP9ojU-IGGaJxbaGeDORrrTOeQTt_RL45uNturQhTnbFpiDM4O1ufS4q7SwY3BnziMC48HTNQkun3Y_v41U-uPGFPuPQZv05xekRejcQlfP8U1-frxw5fbz8X9w6e725v7oheVmoua8Voo0QAfGwajVKKuALqOi6oVNceRNwMMbFSIssdGttApPlaNxFbJajBiTTZn3imGH_mkWe9t6tE54zEckua8AiV4ndesCT9D-xhSijjqKdq9iYtmoE8u6J0-uaBPLmhQOruQh94-8R-6PQ7_Rv7KngHvzwDMXx4tRp16i77HwcasuR6C_R__HyRdmm0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2250632727</pqid></control><display><type>article</type><title>Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists</title><source>Elsevier ScienceDirect Journals</source><creator>Lu, Zhonghui ; Duan, James J.-W. ; Xiao, Haiyun ; Neels, James ; Wu, Dauh-Rurng ; Weigelt, Carolyn A. ; Sack, John S. ; Khan, Javed ; Ruzanov, Max ; An, Yongmi ; Yarde, Melissa ; Karmakar, Ananta ; Vishwakrishnan, Sureshbabu ; Baratam, Venkata ; Shankarappa, Harisha ; Vanteru, Sridhar ; Babu, Venkatesh ; Basha, Mushkin ; Kumar Gupta, Arun ; Kumaravel, Selvakumar ; Mathur, Arvind ; Zhao, Qihong ; Salter-Cid, Luisa M. ; Carter, Percy H. ; Murali Dhar, T.G.</creator><creatorcontrib>Lu, Zhonghui ; Duan, James J.-W. ; Xiao, Haiyun ; Neels, James ; Wu, Dauh-Rurng ; Weigelt, Carolyn A. ; Sack, John S. ; Khan, Javed ; Ruzanov, Max ; An, Yongmi ; Yarde, Melissa ; Karmakar, Ananta ; Vishwakrishnan, Sureshbabu ; Baratam, Venkata ; Shankarappa, Harisha ; Vanteru, Sridhar ; Babu, Venkatesh ; Basha, Mushkin ; Kumar Gupta, Arun ; Kumaravel, Selvakumar ; Mathur, Arvind ; Zhao, Qihong ; Salter-Cid, Luisa M. ; Carter, Percy H. ; Murali Dhar, T.G.</creatorcontrib><description>[Display omitted] An X-ray crystal structure of one of our previously discovered RORγt inverse agonists bound to the RORγt ligand binding domain revealed that the cyclohexane carboxylic acid group of compound 2 plays a significant role in RORγt binding, forming four hydrogen bonding and ionic interactions with RORγt. SAR studies centered around the cyclohexane carboxylic acid group led to identification of several structurally diverse and more potent compounds, including new carboxylic acid analogues 7 and 20, and cyclic sulfone analogues 34 and 37. Notably, compounds 7 and 20 were found to maintain the desirable pharmacokinetic profile of 2.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2019.06.036</identifier><identifier>PMID: 31257087</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>IL-17 ; Inverse agonist ; Retinoic acid-related orphan receptor gamma t ; RORγt ; Th17</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2019-08, Vol.29 (16), p.2265-2269</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-7127363802f810f4637500bb2359372ef28d0d1f6ee4ce8490b62f584e9645da3</citedby><cites>FETCH-LOGICAL-c356t-7127363802f810f4637500bb2359372ef28d0d1f6ee4ce8490b62f584e9645da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X19304160$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31257087$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Zhonghui</creatorcontrib><creatorcontrib>Duan, James J.-W.</creatorcontrib><creatorcontrib>Xiao, Haiyun</creatorcontrib><creatorcontrib>Neels, James</creatorcontrib><creatorcontrib>Wu, Dauh-Rurng</creatorcontrib><creatorcontrib>Weigelt, Carolyn A.</creatorcontrib><creatorcontrib>Sack, John S.</creatorcontrib><creatorcontrib>Khan, Javed</creatorcontrib><creatorcontrib>Ruzanov, Max</creatorcontrib><creatorcontrib>An, Yongmi</creatorcontrib><creatorcontrib>Yarde, Melissa</creatorcontrib><creatorcontrib>Karmakar, Ananta</creatorcontrib><creatorcontrib>Vishwakrishnan, Sureshbabu</creatorcontrib><creatorcontrib>Baratam, Venkata</creatorcontrib><creatorcontrib>Shankarappa, Harisha</creatorcontrib><creatorcontrib>Vanteru, Sridhar</creatorcontrib><creatorcontrib>Babu, Venkatesh</creatorcontrib><creatorcontrib>Basha, Mushkin</creatorcontrib><creatorcontrib>Kumar Gupta, Arun</creatorcontrib><creatorcontrib>Kumaravel, Selvakumar</creatorcontrib><creatorcontrib>Mathur, Arvind</creatorcontrib><creatorcontrib>Zhao, Qihong</creatorcontrib><creatorcontrib>Salter-Cid, Luisa M.</creatorcontrib><creatorcontrib>Carter, Percy H.</creatorcontrib><creatorcontrib>Murali Dhar, T.G.</creatorcontrib><title>Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>[Display omitted] An X-ray crystal structure of one of our previously discovered RORγt inverse agonists bound to the RORγt ligand binding domain revealed that the cyclohexane carboxylic acid group of compound 2 plays a significant role in RORγt binding, forming four hydrogen bonding and ionic interactions with RORγt. SAR studies centered around the cyclohexane carboxylic acid group led to identification of several structurally diverse and more potent compounds, including new carboxylic acid analogues 7 and 20, and cyclic sulfone analogues 34 and 37. Notably, compounds 7 and 20 were found to maintain the desirable pharmacokinetic profile of 2.</description><subject>IL-17</subject><subject>Inverse agonist</subject><subject>Retinoic acid-related orphan receptor gamma t</subject><subject>RORγt</subject><subject>Th17</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9UUuK3DAQFSEh09PJBbIIWvbA2Cl9LNuQzTDkMzAw0CSQnZDt8kSNWnIkd4PvkNvkHjlT1PQky6yKqnr1quo9Qt4wKBkw9W5XdvvelRxYW4IqQahnZMWkkoWQUD0nK2gVFE0rv12Qy5R2AEyClC_JhWC8qqGpV-Tn3YB-tqPtzWyDp2GkU5hz6ZomdNjP9ojU-IGGaJxbaGeDORrrTOeQTt_RL45uNturQhTnbFpiDM4O1ufS4q7SwY3BnziMC48HTNQkun3Y_v41U-uPGFPuPQZv05xekRejcQlfP8U1-frxw5fbz8X9w6e725v7oheVmoua8Voo0QAfGwajVKKuALqOi6oVNceRNwMMbFSIssdGttApPlaNxFbJajBiTTZn3imGH_mkWe9t6tE54zEckua8AiV4ndesCT9D-xhSijjqKdq9iYtmoE8u6J0-uaBPLmhQOruQh94-8R-6PQ7_Rv7KngHvzwDMXx4tRp16i77HwcasuR6C_R__HyRdmm0</recordid><startdate>20190815</startdate><enddate>20190815</enddate><creator>Lu, Zhonghui</creator><creator>Duan, James J.-W.</creator><creator>Xiao, Haiyun</creator><creator>Neels, James</creator><creator>Wu, Dauh-Rurng</creator><creator>Weigelt, Carolyn A.</creator><creator>Sack, John S.</creator><creator>Khan, Javed</creator><creator>Ruzanov, Max</creator><creator>An, Yongmi</creator><creator>Yarde, Melissa</creator><creator>Karmakar, Ananta</creator><creator>Vishwakrishnan, Sureshbabu</creator><creator>Baratam, Venkata</creator><creator>Shankarappa, Harisha</creator><creator>Vanteru, Sridhar</creator><creator>Babu, Venkatesh</creator><creator>Basha, Mushkin</creator><creator>Kumar Gupta, Arun</creator><creator>Kumaravel, Selvakumar</creator><creator>Mathur, Arvind</creator><creator>Zhao, Qihong</creator><creator>Salter-Cid, Luisa M.</creator><creator>Carter, Percy H.</creator><creator>Murali Dhar, T.G.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190815</creationdate><title>Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists</title><author>Lu, Zhonghui ; Duan, James J.-W. ; Xiao, Haiyun ; Neels, James ; Wu, Dauh-Rurng ; Weigelt, Carolyn A. ; Sack, John S. ; Khan, Javed ; Ruzanov, Max ; An, Yongmi ; Yarde, Melissa ; Karmakar, Ananta ; Vishwakrishnan, Sureshbabu ; Baratam, Venkata ; Shankarappa, Harisha ; Vanteru, Sridhar ; Babu, Venkatesh ; Basha, Mushkin ; Kumar Gupta, Arun ; Kumaravel, Selvakumar ; Mathur, Arvind ; Zhao, Qihong ; Salter-Cid, Luisa M. ; Carter, Percy H. ; Murali Dhar, T.G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-7127363802f810f4637500bb2359372ef28d0d1f6ee4ce8490b62f584e9645da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>IL-17</topic><topic>Inverse agonist</topic><topic>Retinoic acid-related orphan receptor gamma t</topic><topic>RORγt</topic><topic>Th17</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Zhonghui</creatorcontrib><creatorcontrib>Duan, James J.-W.</creatorcontrib><creatorcontrib>Xiao, Haiyun</creatorcontrib><creatorcontrib>Neels, James</creatorcontrib><creatorcontrib>Wu, Dauh-Rurng</creatorcontrib><creatorcontrib>Weigelt, Carolyn A.</creatorcontrib><creatorcontrib>Sack, John S.</creatorcontrib><creatorcontrib>Khan, Javed</creatorcontrib><creatorcontrib>Ruzanov, Max</creatorcontrib><creatorcontrib>An, Yongmi</creatorcontrib><creatorcontrib>Yarde, Melissa</creatorcontrib><creatorcontrib>Karmakar, Ananta</creatorcontrib><creatorcontrib>Vishwakrishnan, Sureshbabu</creatorcontrib><creatorcontrib>Baratam, Venkata</creatorcontrib><creatorcontrib>Shankarappa, Harisha</creatorcontrib><creatorcontrib>Vanteru, Sridhar</creatorcontrib><creatorcontrib>Babu, Venkatesh</creatorcontrib><creatorcontrib>Basha, Mushkin</creatorcontrib><creatorcontrib>Kumar Gupta, Arun</creatorcontrib><creatorcontrib>Kumaravel, Selvakumar</creatorcontrib><creatorcontrib>Mathur, Arvind</creatorcontrib><creatorcontrib>Zhao, Qihong</creatorcontrib><creatorcontrib>Salter-Cid, Luisa M.</creatorcontrib><creatorcontrib>Carter, Percy H.</creatorcontrib><creatorcontrib>Murali Dhar, T.G.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Zhonghui</au><au>Duan, James J.-W.</au><au>Xiao, Haiyun</au><au>Neels, James</au><au>Wu, Dauh-Rurng</au><au>Weigelt, Carolyn A.</au><au>Sack, John S.</au><au>Khan, Javed</au><au>Ruzanov, Max</au><au>An, Yongmi</au><au>Yarde, Melissa</au><au>Karmakar, Ananta</au><au>Vishwakrishnan, Sureshbabu</au><au>Baratam, Venkata</au><au>Shankarappa, Harisha</au><au>Vanteru, Sridhar</au><au>Babu, Venkatesh</au><au>Basha, Mushkin</au><au>Kumar Gupta, Arun</au><au>Kumaravel, Selvakumar</au><au>Mathur, Arvind</au><au>Zhao, Qihong</au><au>Salter-Cid, Luisa M.</au><au>Carter, Percy H.</au><au>Murali Dhar, T.G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2019-08-15</date><risdate>2019</risdate><volume>29</volume><issue>16</issue><spage>2265</spage><epage>2269</epage><pages>2265-2269</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>[Display omitted] An X-ray crystal structure of one of our previously discovered RORγt inverse agonists bound to the RORγt ligand binding domain revealed that the cyclohexane carboxylic acid group of compound 2 plays a significant role in RORγt binding, forming four hydrogen bonding and ionic interactions with RORγt. SAR studies centered around the cyclohexane carboxylic acid group led to identification of several structurally diverse and more potent compounds, including new carboxylic acid analogues 7 and 20, and cyclic sulfone analogues 34 and 37. Notably, compounds 7 and 20 were found to maintain the desirable pharmacokinetic profile of 2.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31257087</pmid><doi>10.1016/j.bmcl.2019.06.036</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2019-08, Vol.29 (16), p.2265-2269
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_2250632727
source Elsevier ScienceDirect Journals
subjects IL-17
Inverse agonist
Retinoic acid-related orphan receptor gamma t
RORγt
Th17
title Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T02%3A44%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20potent,%20selective%20and%20orally%20bioavailable%20phenyl%20((R)-3-phenylpyrrolidin-3-yl)sulfone%20analogues%20as%20ROR%CE%B3t%20inverse%20agonists&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Lu,%20Zhonghui&rft.date=2019-08-15&rft.volume=29&rft.issue=16&rft.spage=2265&rft.epage=2269&rft.pages=2265-2269&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2019.06.036&rft_dat=%3Cproquest_cross%3E2250632727%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2250632727&rft_id=info:pmid/31257087&rft_els_id=S0960894X19304160&rfr_iscdi=true